Lg Cwd
icon-nav-help
Need Help

Submit your question to our team of health care professionals.

icon-nav-current-questions
Current Question

See what's on the mind of the community right now.

icon-conf-speakers-at-a-glance
Meet the Team

Learn more about our world-renowned team.

icon-nav-archives
DTeam Archives

Review the entire archive according to the date it was posted.

icon-question-mark
September 26, 2001

Complications

Question from Cortland, Ohio, USA:

I have read a little about the use of C-peptide to decrease the complications of diabetes. Do you have any information on this topic?

Answer:

A role for C-peptide in the treatment of the complications of type 1A (autoimmune) diabetes in humans was first proposed by a group at the Karolinska Institute in Stockholm by a Wahren Johanssen (See C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat). You can find several more up to date reports if you search PubMed under ‘C-peptide in diabetes treatment’. These are mostly in laboratory animals and relate to the neuropathies.

Although the encouraging results seemed valid, they have not been striking enough for anyone to pursue the extraordinarily costly approach to the clinical trials needed for FDA approval in the U.S. Most probably, any C-peptide deficiency will ultimately be solved by advances in islet cell transplants.

DOB